Tapewire

NYSE · USD

COR

Cencora, Inc.

Export transactions ↓
Tapewire entity
2994
SEC CIK
0001140859
Parsed reports
801

Last 12 months

Inside the activity.

3 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202504
Jan 202601
Feb 202602
Mar 202600
Apr 202600
May 202610
Jun 202620
Jul 202600
Aug 202601
Sep 202602
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2024 Filed Mar 13, 2024 20:37 UTC GrantCommon Stock 1,053 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · nonDerivative · entry 2

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,376

F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:35 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · nonDerivative · entry 2

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,762

F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:31 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000040 · wk-form4_1710361877.xml · nonDerivative · entry 1

GREENBERG LON R · CIK 0001234234 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,062

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 01/15/2026.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:30 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · nonDerivative · entry 2

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,819

F2 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:18 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000036 · wk-form4_1710361123.xml · nonDerivative · entry 1

Baumann Werner · CIK 0001986505 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,563

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Receipt of shares deferred until 01/15/2028.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:15 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000033 · wk-form4_1710360896.xml · nonDerivative · entry 1

Miller Redonda · CIK 0001891346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,405

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Delivery of vested shares deferred until 01/03/2029.

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:13 UTC GrantCommon Stock 843 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000031 · wk-form4_1710360769.xml · nonDerivative · entry 1

Tyler Lauren M · CIK 0001765744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,563

F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant. Delivery of vested shares deferred until 03/12/2026.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:33 UTC Exercise / conversionRestricted Stock Units · Derivative 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000042 · wk-form4_1710361992.xml · derivative · entry 3

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,593 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:33 UTC Exercise / conversionCommon Stock 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000042 · wk-form4_1710361992.xml · nonDerivative · entry 1

HYLE KATHLEEN W · CIK 0001117310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:43 UTC
Battaglia SilvanaExecutive Vice President
GrantRestricted Stock Units · Derivative 8,415 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000052 · wk-form4_1710362578.xml · derivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,415

Underlying: Common Stock · 8,415 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:41 UTC
Cleary James FChief Financial Officer
GrantRestricted Stock Units · Derivative 12,623 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000050 · wk-form4_1710362478.xml · derivative · entry 1

Cleary James F · CIK 0001333281 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,623

Underlying: Common Stock · 12,623 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:39 UTC
Campbell Elizabeth SExecutive Vice President
GrantRestricted Stock Units · Derivative 12,623 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000048 · wk-form4_1710362358.xml · derivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,623

Underlying: Common Stock · 12,623 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F2 · derivative.exercise_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

F2 · derivative.expiration_date: The restricted stock units will vest in full on March 11, 2026, which is the second anniversary of the grant date, subject to the reporting person's continued employment through such date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:37 UTC Exercise / conversionRestricted Stock Units · Derivative 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · derivative · entry 3

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,593 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:37 UTC GrantCommon Stock 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000046 · wk-form4_1710362234.xml · nonDerivative · entry 1

DURCAN DERMOT MARK · CIK 0001202358 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,323

F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:35 UTC Exercise / conversionRestricted Stock Units · Derivative 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · derivative · entry 3

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,593 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:35 UTC Exercise / conversionCommon Stock 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000044 · wk-form4_1710362099.xml · nonDerivative · entry 1

GOCHNAUER RICHARD W · CIK 0001214315 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC Exercise / conversionRestricted Stock Units · Derivative 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · derivative · entry 3

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,593 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of Cencora, Inc.

F4 · derivative.exercise_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

F4 · derivative.expiration_date: 2021 annual grant of restricted stock units received for no consideration and vested 100% on March 11, 2024.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 20:30 UTC Exercise / conversionCommon Stock 1,593 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000039 · wk-form4_1710361815.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,976

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Reflects the vesting of 2021 annual grant of restricted stock units described in Table II.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:41 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · derivative · entry 3

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:41 UTC
Battaglia SilvanaExecutive Vice President
Tax withholdingCommon Stock 537 $237.47 $127,521.39
Disclosure

SEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 2

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,354.803

Read SEC document
March 08, 2024 Filed Mar 11, 2024 20:41 UTC
Battaglia SilvanaExecutive Vice President
Exercise / conversionCommon Stock 1,211 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000029 · wk-form4_1710189656.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,891.803

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 21:14 UTC
Clark GinaExecutive Vice President
SaleCommon Stock 1,100 $230.48 $253,528.00
Disclosure

SEC source: 0001140859-24-000027 · wk-form4_1707945265.xml · nonDerivative · entry 1

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,802

Read SEC document
February 07, 2024 Filed Feb 9, 2024 12:00 UTC SaleCommon Stock 4,212,395 $235.41 $991,639,906.95
Disclosure

SEC source: 0000899243-24-000165 · doc4.xml · nonDerivative · entry 1

Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner

Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 26,277,561

F4 · kind: Represents sale pursuant to Rule 144 (4,000,0000 shares) and a sale in private transaction to the Issuer (212,395 shares), in each case, by WBA Holdings.

F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 14, 2016, January 6, 2021, June 3, 2021, May 12, 2022, August 4, 2022, November 9, 2022, December 12, 2022, May 15, 2023, June 20, 2023, August 7, 2023, November 14, 2023 and February 9, 2024 (the "Schedule 13D"), the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by the Reporting Person on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement").

F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person.

F3 · ownership.nature: As described in the Schedule 13D, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 21:13 UTC GrantCommon Stock 132 $236.92 $31,273.44
Disclosure

SEC source: 0001140859-24-000025 · wk-form4_1707167573.xml · nonDerivative · entry 1

NALLY DENNIS M · CIK 0001685596 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,383

F1 · shares: Shares of common stock issued in lieu of $31,250 quarterly cash retainer per the terms of the Registrant's Non-Employee Director Compensation Program.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 21:10 UTC GrantCommon Stock 106 $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000023 · wk-form4_1707167427.xml · nonDerivative · entry 1

Baumann Werner · CIK 0001986505 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720

F1 · shares: Grant of Restricted Stock Units issued in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 01/15/2028.

F1 · price: Grant of Restricted Stock Units issued in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 01/15/2028.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 21:08 UTC GrantCommon Stock 106 $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000021 · wk-form4_1707167311.xml · nonDerivative · entry 1

Tyler Lauren M · CIK 0001765744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 720

F1 · shares: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025.

F1 · price: Grant of Restricted Stock Units received in lieu of $25,000 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of vested shares deferred until 03/01/2025.

Read SEC document
January 15, 2024 Filed Jan 17, 2024 21:04 UTC Exercise / conversionCommon Stock 1,340 $219.43 $294,036.20
Disclosure

SEC source: 0001140859-24-000014 · wk-form4_1705525458.xml · nonDerivative · entry 1

GREENBERG LON R · CIK 0001234234 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Annual grant of restricted stock units received for no consideration that previously vested 100% on March 1, 2021, the third anniversary of the date of grant. Receipt of these shares was deferred until January 15, 2024.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:12 UTC
Battaglia SilvanaExecutive Vice President
GrantCommon Stock 52.986 $174.57 $9,249.92
Disclosure

SEC source: 0001140859-24-000008 · wk-form4_1704748350.xml · nonDerivative · entry 1

Battaglia Silvana · CIK 0001774724 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,680.803

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:10 UTC
Campbell Elizabeth SExecutive Vice President
GrantCommon Stock 57.569 $174.57 $10,049.99
Disclosure

SEC source: 0001140859-24-000006 · wk-form4_1704748230.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,223.42

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:09 UTC
Donato Leslie EEVP & Chief Strategy Officer
GrantCommon Stock 40.097 $174.57 $6,999.85
Disclosure

SEC source: 0001140859-24-000004 · wk-form4_1704748133.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,558.849

F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:10 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionRestricted Stock Units · Derivative 252 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · derivative · entry 3

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252

Underlying: Common Stock · 252 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025.

F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025.

F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:10 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Tax withholdingCommon Stock 86 $210.33 $18,088.38
Disclosure

SEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · nonDerivative · entry 2

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,042

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:10 UTC
Krikorian LazarusSVP & Chief Accounting Officer
Exercise / conversionCommon Stock 252 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-24-000002 · wk-form4_1704402590.xml · nonDerivative · entry 1

Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received for no consideration that vest in three equal installments on 01/03/2023, 01/03/2024, and 01/03/2025.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 21:00 UTC
Donato Leslie EEVP & Chief Strategy Officer
SaleCommon Stock 3,400 $202.13 $687,242.00
Disclosure

SEC source: 0001140859-23-000217 · wk-form4_1703624417.xml · nonDerivative · entry 1

Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,518.752

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:09 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
GiftCommon Stock 3,600 $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000215 · wk-form4_1702933777.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,088

F1 · shares: On December 15, 2023, the reporting person donated 3,600 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionRestricted Stock Units · Derivative 1,015 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · derivative · entry 4

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,393

Underlying: Common Stock · 1,015 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F3 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F2 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F2 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Tax withholdingCommon Stock 1,015 $203.72 $206,775.80
Disclosure

SEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 3

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,688

F3 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F4 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 1,015 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:22 UTC
COLLIS STEVEN HDirector · Chairman, President & CEO
SaleCommon Stock 42,885 $203.18 $8,713,374.30
Disclosure

SEC source: 0001140859-23-000213 · wk-form4_1702675367.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,688

F1 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $203.00 to $203.62 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:21 UTC
Campbell Elizabeth SExecutive Vice President
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 5,162 $0.00 Strike: $89.58 $0.00
Disclosure

SEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · derivative · entry 3

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,162 shares

Expires 2025-11-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:21 UTC
Campbell Elizabeth SExecutive Vice President
SaleCommon Stock 5,162 $203.13 $1,048,577.71
Disclosure

SEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · nonDerivative · entry 2

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,165.851

F1 · price: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $202.910 to $203.300 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:21 UTC
Campbell Elizabeth SExecutive Vice President
Exercise / conversionCommon Stock 5,162 $89.58 $462,411.96
Disclosure

SEC source: 0001140859-23-000211 · wk-form4_1702675268.xml · nonDerivative · entry 1

Campbell Elizabeth S · CIK 0001882641 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,327.851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:19 UTC
Cleary James FChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 307 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · derivative · entry 3

Cleary James F · CIK 0001333281 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,011

Underlying: Common Stock · 307 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/8/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:19 UTC
Cleary James FChief Financial Officer
Tax withholdingCommon Stock 307 $203.72 $62,542.04
Disclosure

SEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · nonDerivative · entry 2

Cleary James F · CIK 0001333281 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,066.3479

F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/8/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:19 UTC
Cleary James FChief Financial Officer
Exercise / conversionCommon Stock 307 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000209 · wk-form4_1702675168.xml · nonDerivative · entry 1

Cleary James F · CIK 0001333281 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,373.3479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:17 UTC
Mauch Robert P.Executive Vice President & COO
Exercise / conversionRestricted Stock Units · Derivative 487 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · derivative · entry 3

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,709

Underlying: Common Stock · 487 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:17 UTC
Mauch Robert P.Executive Vice President & COO
Tax withholdingCommon Stock 487 $203.72 $99,211.64
Disclosure

SEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · nonDerivative · entry 2

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,099

F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligation and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:17 UTC
Mauch Robert P.Executive Vice President & COO
Exercise / conversionCommon Stock 487 Not disclosed Not disclosed
Disclosure

SEC source: 0001140859-23-000207 · wk-form4_1702675071.xml · nonDerivative · entry 1

Mauch Robert P. · CIK 0001633897 · Executive Vice President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:16 UTC
Clark GinaExecutive Vice President
Exercise / conversionRestricted Stock Units · Derivative 137 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001140859-23-000205 · wk-form4_1702674962.xml · derivative · entry 3

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,116

Underlying: Common Stock · 137 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F2 · shares: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligations and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F1 · derivative.exercise_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

F1 · derivative.expiration_date: Grant of restricted stock units received on 11/08/2023 for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 21:16 UTC
Clark GinaExecutive Vice President
Tax withholdingCommon Stock 137 $203.72 $27,909.64
Disclosure

SEC source: 0001140859-23-000205 · wk-form4_1702674962.xml · nonDerivative · entry 2

Clark Gina · CIK 0001625811 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,902

F2 · kind: Reflects partial lapsing of restrictions on installment scheduled to vest on 11/08/2024 to cover FICA obligations and associated income taxes for retirement eligible employees on 2023 grant of restricted stock units.

F3 · price: The closing price of the Company's common stock on 12/13/2023, the date used to calculate the FICA tax obligation in accordance with IRS rules.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.